BC Advantage Crosses $4 Million in Sales of 2007 Allocation

Vancouver, July 17, 2007 - BC Advantage Funds (VCC) Ltd. announced today that it has now sold over $4 million, or 40%, of its $10 million 2007 equity allocation. BC resident taxpayers who purchase Advantage shares receive a 30% refundable provincial tax credit. The shares are RRSP-RRIF eligible and can be purchased up to a maximum of $200,000 per investor annually.

Advantage President and Partner, Jim Heppell, commented, "We are experiencing our fastest fundraising start in the history of Advantage. We are well ahead of our sales projections and anticipate being sold out of our 2007 equity allocation well before the end of the RSP season".

In 2006, strong demand for Advantage's shares led to an early sell out of the Advantage Venture Fund (BCA 100). With additional equity allocation grants from the Investment Capital Branch, Advantage reached $13.4 million in sales in 2006 - the highest amount ever raised by the fund in one year.

In separate news, Advantage announced that the Net Asset Value (NAV) for the Advantage Venture Fund recently moved through $10.00 per share. The increase in NAV resulted from the rise in value of some of the Venture Fund's early investments, in companies such as Protox Therapeutics and Phero Tech International.

About Advantage and the BC Tech Fund

Advantage offers everyone in BC the opportunity to invest in some of the Province's most promising life science, technology and clean-technology companies. Advantage investors receive a 30% refundable tax credit from the BC government on investments of up to $200,000 per year.

For more information about Advantage, please review our prospectus, visit our website at www.bcadvantagefunds.com or contact our Vice President, Sales and Marketing, Ray Matthews at rmatthews@lionscapital.com or 604.818.7778.

« Back to News